Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(11%)
Results Posted
40%(2 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
4
44%
Ph phase_3
2
22%
Ph early_phase_1
1
11%

Phase Distribution

2

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
Phase 24 (50.0%)
Phase 32 (25.0%)

Trials by Status

completed556%
terminated222%
unknown111%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
completedphase_2

Ethosuximide to Treat IBS

NCT02973542
completed

Population Pharmacokinetics of Antiepileptic in Pediatrics

NCT03196466
completedearly_phase_1

Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.

NCT03887624
unknownphase_2

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

NCT04431778
completedphase_3

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02973542Phase 2

Ethosuximide to Treat IBS

Completed
NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed
NCT03887624Early Phase 1

Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.

Completed
NCT04431778Phase 2

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Unknown
NCT00088452Phase 3

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Completed
NCT04217733Phase 3

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Recruiting
NCT01278004Phase 2

Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)

Completed
NCT01122381Phase 1

Comparison of a Drug and Placebo in the Prevention of Migraine Headaches

Terminated
NCT00689585Phase 2

Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)

Terminated

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9